OnKure Therapeutics, Inc.
Developing less toxic, tumor-agnostic kinase inhibitors for precision cancer therapy.
OKUR | NDAQ
Overview
Corporate Details
- ISIN(s):
- US75974E1038 (+1 more)
- LEI:
- Country:
- United States of America
- Address:
- 6707 WINCHESTER CIRCLE, SUITE 400, 80301 BOULDER
- Website:
- https://onkuretherapeutics.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
OnKure Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on discovering and developing precision medicines to treat cancer. The company is building a broad pipeline of potentially best-in-class, tumor-agnostic therapies that target biologically validated drivers of cancer. Its approach involves developing novel, less toxic kinase inhibitor drugs. OnKure emphasizes its team of proven drug discovery and development scientists with expertise in cancer biology and medicinal chemistry.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all OnKure Therapeutics, Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for OnKure Therapeutics, Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for OnKure Therapeutics, Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
